These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9447534)

  • 21. Potential for treatment of anemia of prematurity with recombinant human erythropoietin.
    Phibbs RH
    Curr Opin Pediatr; 1995 Apr; 7(2):140-5. PubMed ID: 7787927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin production by macrophages from preterm infants: implications regarding the cause of the anemia of prematurity.
    Ohls RK; Li Y; Trautman MS; Christensen RD
    Pediatr Res; 1994 Feb; 35(2):169-70. PubMed ID: 8165050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoiesis and the approach to anemia in premature infants.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):97-9. PubMed ID: 23025780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity.
    Ohls RK
    Paediatr Drugs; 2002; 4(2):111-21. PubMed ID: 11888358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin responsive progenitors in anaemia of prematurity.
    Emmerson AJ; Westwood NB; Rackham RA; Stern CM; Pearson TC
    Arch Dis Child; 1991 Jul; 66(7 Spec No):810-1. PubMed ID: 1863130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal anemia.
    Aher S; Malwatkar K; Kadam S
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):239-47. PubMed ID: 18411074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of erythropoietin in neonates.
    Ohls RK
    Clin Perinatol; 2000 Sep; 27(3):681-96. PubMed ID: 10986635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor as marker for tissue hypoxia and transfusion need in anemic infants: a prospective clinical study.
    Tschirch E; Weber B; Koehne P; Guthmann F; von Gise A; Wauer RR; Rüdiger M
    Pediatrics; 2009 Mar; 123(3):784-90. PubMed ID: 19255003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of recombinant human erythropoietin in the treatment of anemia of prematurity].
    Rosati E; Latini G; De Mitri B; Quartulli L; Caliandro P
    Pediatr Med Chir; 1995; 17(1):45-8. PubMed ID: 7739926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.
    Bierer R; Peceny MC; Hartenberger CH; Ohls RK
    Pediatrics; 2006 Sep; 118(3):e635-40. PubMed ID: 16908620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of recombinant human erythropoietin (EPO) treatment in a neonate with hyporegenerative anemia following Rh isoimmunization in spite of normal serum Epo level.
    Erduran E; Bahadir A
    Pediatr Hematol Oncol; 2011 Nov; 28(8):721-2. PubMed ID: 21875319
    [No Abstract]   [Full Text] [Related]  

  • 33. A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age.
    Ross MP; Christensen RD; Rothstein G; Koenig JM; Simmons MA; Noble NA; Kimura RE
    J Perinatol; 1989 Sep; 9(3):246-53. PubMed ID: 2681578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity.
    Pathak A; Roth P; Piscitelli J; Johnson L
    Arch Dis Child Fetal Neonatal Ed; 2003 Jul; 88(4):F324-8. PubMed ID: 12819167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia.
    Rosebraugh MR; Widness JA; Nalbant D; Veng-Pedersen P
    Transfusion; 2013 Jun; 53(6):1353-60. PubMed ID: 23033916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of erythropoietin on erythrocyte deformability in non-transfused preterm infants.
    Klipp M; Holzwarth AU; Poeschl JM; Nelle M; Linderkamp O
    Acta Paediatr; 2007 Feb; 96(2):253-6. PubMed ID: 17429915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum erythropoietin titres in the anaemia of premature infants.
    Saito T; Urabe A; Uramoto K; Hashimoto Y; Takaku F
    Br J Haematol; 1983 May; 54(1):53-8. PubMed ID: 6849837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red blood cell transfusion in preterm infants: restrictive versus liberal policy.
    Chirico G; Beccagutti F; Sorlini A; Motta M; Perrone B
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():20-2. PubMed ID: 21942584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human erythropoietin in anemia of prematurity.
    Whitehall JS; Patole SK; Campbell P
    Indian Pediatr; 1999 Jan; 36(1):17-27. PubMed ID: 10709119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum erythropoietin concentrations in symptomatic infants during the anaemia of prematurity.
    Meyer J; Sive A; Jacobs P
    Arch Dis Child; 1992 Jul; 67(7 Spec No):818-21. PubMed ID: 1519982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.